Status:
COMPLETED
Innate Lymphoid Cells in Septic Shock
Lead Sponsor:
Assistance Publique Hopitaux De Marseille
Conditions:
Septic Shock
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Less than ten years after their intial description, the comprehension of Innate Lymphoid Cells (ILCs) biology is rapidly improving. They can be classified into four subgroups (ILCs 1, 2, 3 and NK cell...
Detailed Description
Septic shock is a major public health problem. Even if mortality is decreasing, it's still high. Sepsis is a heterogeneous syndrome that encompasses a gamut of immune responses occurring during the ho...
Eligibility Criteria
Inclusion
- Major patient
- patient admitted to resuscitation for septic shock
- patient admitted to intensive care for a serious condition and with no progressive infection at the time of collection
Exclusion
- Minor patient
- Patient with therepeutic limitations
- Bone marrow failure
Key Trial Info
Start Date :
August 2 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 9 2023
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03297203
Start Date
August 2 2017
End Date
August 9 2023
Last Update
August 14 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital de la Timone Assistance Publique Hôpitaux de Marseille
Marseille, France, 13354